DALLAS, April 2, 2015 \/PRNewswire\/ -- <\/p>\n
Lifescienceindustryresearch.com adds \"Complete 2015-16 Induced Pluripotent Stem Cell (iPSC) Industry Report\" in its store. Recent months have seen the first iPSC clinical trial in humans, creation of the world's largest iPSC Biobank, major funding awards, a historic challenge to the \"Yamanaka Patent\", a Supreme Court ruling affecting industry patent rights, the announcement of an iPSC cellular therapy clinic scheduled to open in 2019, and much more. Furthermore, iPSC patent dominance continues to cluster in specific geographic regions, while clinical trial and scientific publication trends give clear indicators of what may happen in the industry in 2015 and beyond. <\/p>\n
Is it worth it to get informed about rapidly-evolving market conditions and identify key industry trends that will give an advantage over the competition? <\/p>\n
BrowsetheReportComplete 2015-16 Induced Pluripotent Stem Cell (iPSC) Industry Reportathttp:\/\/www.lifescienceindustryresearch.com\/complete-2013-14-induced-pl .... <\/p>\n
Induced pluripotent stem cells represent a promising tool for use in the reversal and repair of many previously incurable diseases. The cell type represents one of the most promising advances discovered within the field of stem cell research during the past decade, making this a valuable industry report for both companies and investors to claim in order to optimally position themselves to sell iPSC products. To profit from this lucrative and rapidly expanding market, you need to understand your key strengths relative to the competition, intelligently position your products to fill gaps in the market place, and take advantage of crucial iPSC trends. <\/p>\n
Report Applications <\/p>\n
This global strategic report is produced for: Management of Stem Cell Product Companies, Management of Stem Cell Therapy Companies, Stem Cell Industry Investors <\/p>\n
It is designed to increase your efficiency and effectiveness in: <\/p>\n
Four Primary Areas of Commercialization <\/p>\n
There are currently four major areas of commercialization for induced pluripotent stem cells, as described below: <\/p>\n
<\/p>\n
See the original post:<\/p>\n
Induced Pluripotent Stem Cell (iPSC) Industry Complete Report 2015 - 2016<\/a><\/p>\n","protected":false},"excerpt":{"rendered":" DALLAS, April 2, 2015 \/PRNewswire\/ -- Lifescienceindustryresearch.com adds \"Complete 2015-16 Induced Pluripotent Stem Cell (iPSC) Industry Report\" in its store. Continue reading